[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Pharmdca @Pharmdca on x 125.9K followers
Created: 2025-06-30 21:57:51 UTC
$PTGX announced triple agonist for Obesity similar to $LLY drug Retatrutide First it’s pre clinical Second have you seen safety issues with Retatrutide 🤷♂️🤷♂️ If not see the slides below. No Bueno ⬇️⬇️
Retatrutide aka $PTGX drug Look at CV signal of arrhythmias, Cardiac arrhythmias, Hypersensitivity, Biliary disorder. A drug that shows cardiac arrhythmias has minimal chance of FDA approval
XXXXX engagements
Related Topics $lly $ptgx eli lilly stocks healthcare